Clinical Trials Directory

Trials / Unknown

UnknownNCT05314842

Pulpotomy in Primary Molars Treated With Premixed Bio-ceramic MTA Versus Formocresol

Clinical and Radiographic Evaluation of Pulpotomy in Primary Molars Treated With Premixed Bio-ceramic MTA Versus Formocresol Among a Group of Egyptian Children: A Pilot Study.

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Sarah Abdelbar Mahmoud · Academic / Other
Sex
All
Age
4 Years – 6 Years
Healthy volunteers
Accepted

Summary

examine the results of pulpotomy in primary molars using premixed bioceramic MTA versus Formocresol. Clinical and radiographic success rates were used as outcomes.

Detailed description

Primary outcome: Soft-tissue pathology * Post-treatment swelling will be assessed through visual examination by the operator, either intraorally or extra orally. * Sinus tract or fistula will be assessed through visual examination by the operator Secondary outcomes: 1. Pain to the percussion will be assessed by gentle tapping on the tooth with the end of a dental mirror 2. mobility will be assessed through the back of two mirrors 3. radiographic assessments:- for any radiolucency and pathologic root resorption (periapical or bifurcation) will be examined (present or not). clinical assessment on every recall visit during the 3-, 6-, and 12-month follow-up period. • These radiographic assessments will be performed as baseline data at the first visit following the operating procedure, as well as at 3, 6, and 12 months after the baseline.

Conditions

Interventions

TypeNameDescription
DRUGFormocresoldressing agents in pulpotomized primary molas using formocresol in cariously exposed vital primary molars
DRUGPremixed bioceramic MTAdressing agents in pulpotomized primary molas using premixed bioceramic MTA in cariously exposed vital primary molars

Timeline

Start date
2022-04-01
Primary completion
2023-04-01
Completion
2023-05-01
First posted
2022-04-06
Last updated
2022-04-06

Source: ClinicalTrials.gov record NCT05314842. Inclusion in this directory is not an endorsement.